Vanda Pharmaceuticals Inc.

MASSACHUSETTS FINANCIAL SERVICES CO /MA/ VNDA

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/22/2026

Shares

103,446

Value ($000)

912

Weight

0.0%

2020 Q3 - 2025 Q4 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/22/2026	912	0.0%	103,446	12/31/2025
2025 Q3	10/29/2025	693	0.0%	138,805	9/30/2025
2025 Q2	8/8/2025	836	0.0%	177,050	6/30/2025
2025 Q1	5/2/2025	803	0.0%	174,859	3/31/2025
2024 Q4	2/12/2025	857	0.0%	178,847	12/31/2024
2024 Q3	11/12/2024	864	0.0%	184,181	9/30/2024
2024 Q1	5/14/2024	560	0.0%	136,340	3/31/2024
2023 Q4	2/8/2024	577	0.0%	136,643	12/31/2023
2023 Q3	11/8/2023	609	0.0%	140,959	9/30/2023
2023 Q2	8/9/2023	965	0.0%	146,360	6/30/2023
2023 Q1	5/10/2023	1,017	0.0%	149,809	3/31/2023
2022 Q4	2/13/2023	1,138	0.0%	154,043	12/31/2022
2022 Q3	11/9/2022	1,490	0.0%	150,782	9/30/2022
2022 Q2	8/9/2022	1,659	0.0%	152,157	6/30/2022
2022 Q1	5/11/2022	1,712	0.0%	151,389	3/31/2022
2021 Q4	2/10/2022	2,351	0.0%	149,835	12/31/2021
2021 Q3	11/10/2021	2,620	0.0%	152,870	9/30/2021
2021 Q2	8/13/2021	3,331	0.0%	154,876	6/30/2021
2021 Q1	5/13/2021	1,258	0.0%	83,775	3/31/2021
2020 Q4	5/12/2021	1,290	0.0%	98,164	12/31/2020
2020 Q3	11/12/2020	958	0.0%	99,151	9/30/2020